Nordic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 14-12-2024
- Paid Up Capital ₹ 1.15 M
as on 14-12-2024
- Company Age 27 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.70 M
as on 14-12-2024
- Revenue 50.65%
(FY 2022)
- Profit 293.77%
(FY 2022)
- Ebitda 2361.59%
(FY 2022)
- Net Worth 7.41%
(FY 2022)
- Total Assets 30.85%
(FY 2022)
About Nordic Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.15 M.
The company currently has active open charges totaling ₹4.70 M.
Manoj Poddar, Manish Poddar, Banwari Poddar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231DL1997PLC089698
- Company No.
089698
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Sep 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nordic Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Poddar  | Director | 16-Sep-1997 | Current |
| Manish Poddar | Director | 16-Sep-1997 | Current |
| Banwari Poddar | Director | 16-Sep-1997 | Current |
| Kusum Poddar | Director | 30-Mar-2015 | Current |
Financial Performance of Nordic Pharmaceuticals.
Nordic Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.65% increase. The company also saw a substantial improvement in profitability, with a 293.77% increase in profit. The company's net worth moved up by a moderate rise of 7.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nordic Pharmaceuticals?
In 2022, Nordic Pharmaceuticals had a promoter holding of 97.75% and a public holding of 2.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alaknanda Cruiseline Private LimitedActive 7 years 8 monthsManoj Poddar, Manish Poddar and 1 more are mutual person
Nordic Formulations Private LimitedActive 25 years 3 monthsManoj Poddar, Manish Poddar and 2 more are mutual person
- Kewat Hospitalities Private LimitedActive 9 months 2 days
Manoj Poddar and Manish Poddar are mutual person
Charges (Loans)
₹4.70 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2014 | Bank Of India | ₹0.70 M | Open |
| 01 Feb 1999 | Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Nordic Pharmaceuticals?
Unlock and access historical data on people associated with Nordic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nordic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nordic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
